{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:22Z","timestamp":1761178462801,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.canrad.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T18:46:34Z","timestamp":1499107594000},"page":"404-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radioth\u00e9rapie st\u00e9r\u00e9otaxique hypofractionn\u00e9e des m\u00e9tastases surr\u00e9naliennes"],"prefix":"10.1016","volume":"21","author":[{"given":"G.","family":"Dupic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Biau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Belli\u00e8re-Calandry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lapeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2017.05.005_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/COC.0b013e3181dbb727","article-title":"Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer","volume":"34","author":"Oshiro","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11912-012-0240-1","article-title":"Management of non-small cell lung cancer with oligometastasis","volume":"14","author":"Villaruz","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.canrad.2017.05.005_bib0020","article-title":"Minimally invasive stereotactical radio-ablation of adrenal metastases as an alternative to surgery","author":"Franzese","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.canrad.2017.05.005_bib0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/bjs.1800830432","article-title":"Adrenalectomy for metastatic disease to the adrenal glands","volume":"83","author":"Lo","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.canrad.2017.05.005_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-7-126","article-title":"Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review","volume":"7","author":"Almaghrabi","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/jrr\/rrw006","article-title":"Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach","author":"Ricardi","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2017.05.005_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PPO.0000000000000143","article-title":"Radiation therapy for oligometastatic non-small cell lung cancer: theory and practice","volume":"21","author":"Rusthoven","year":"2015","journal-title":"Cancer J"},{"key":"10.1016\/j.canrad.2017.05.005_bib0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","article-title":"Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (NCT01282450)","volume":"7","author":"De Ruysscher","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0055","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s12094-013-1008-2","article-title":"Treatment outcome for patients with primary NSCLC and synchronous solitary metastasis","volume":"15","author":"Xu","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02841860802662722","article-title":"Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis","volume":"48","author":"Rusthoven","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0065","first-page":"1677","article-title":"Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment","volume":"25","author":"Mehta","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0070","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0b013e3182745948","article-title":"Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene addicted non-small cell lung cancer","volume":"7","author":"Weickhardt","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10555-015-9559-z","article-title":"Radiation therapy for oligometastatic non-small cell lung cancer","volume":"34","author":"Salama","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.canrad.2017.05.005_bib0080","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1982.03330050063034","article-title":"Successful treatment of adrenal metastases from large cell carcinoma of the lung","volume":"248","author":"Twomey","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2017.05.005_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2015.04.009","article-title":"SABR for aggressive local therapy of metastatic cancer: a new paradigm for metastatic non-small cell lung cancer","volume":"89","author":"Westover","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2017.05.005_bib0090","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2014.56.7412","article-title":"Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer","volume":"32","author":"Iyengar","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2016.07.013","article-title":"Immune modulation by hypofractionated stereotactic radiation therapy: therapeutic implications","volume":"120","author":"Popp","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/107327481602300105","article-title":"Stereotactic body radiotherapy in the management of oligometastatic disease","volume":"23","author":"Ahmed","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.canrad.2017.05.005_bib0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2015.11.015","article-title":"The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer","volume":"92","author":"Guerrero","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2017.05.005_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/1471-2407-12-305","article-title":"Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial","volume":"12","author":"Palma","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2017.05.005_bib0115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.canrad.2017.05.005_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clon.2009.12.003","article-title":"Stereotactic body radiotherapy: a review","volume":"22","author":"Martin","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0125","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.canrad.2014.02.008","article-title":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique extracr\u00e2nienne et oligom\u00e9tastases","volume":"18","author":"Bourgier","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2017.05.005_bib0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2214\/ajr.179.3.1790559","article-title":"Imaging of adrenal incidentalomas: current status","volume":"179","author":"Dunnick","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0221-0363(09)72535-1","article-title":"Conduite \u00e0 tenir devant un incidentalome surr\u00e9nalien\u00a0: scanner\u00a0\u2013\u00a0IRM","volume":"90","author":"Legmann","year":"2009","journal-title":"J Radiol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0145","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1586\/era.12.125","article-title":"Stereotactic body radiation therapy for metastasis to the adrenal glands","volume":"12","author":"Shiue","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.canrad.2017.05.005_bib0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11934-009-0012-0","article-title":"Surgical management of metastases to the adrenal gland: open, laparoscopic and ablative approaches","volume":"10","author":"Uberoi","year":"2009","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.canrad.2017.05.005_bib0155","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1245\/s10434-007-9520-7","article-title":"Laparoscopic adrenalectomy for isolated adrenal metastasis","volume":"14","author":"Strong","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0160","first-page":"181","article-title":"Adrenalectomy for isolated adrenal metastases from non-adrenal cancer","volume":"17","author":"Paul","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0165","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2008.03.013","article-title":"Real-time tumor-tracking radiotherapy for adrenal tumors","volume":"87","author":"Katoh","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0170","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0175","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ctrv.2014.04.001","article-title":"Surgical and ablative therapies for the management of adrenal \u201coligometastases\u201d\u00a0\u2013\u00a0a systematic review","volume":"40","author":"Gunjur","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2017.05.005_bib0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fonc.2015.00185","article-title":"A retrospective review of CyberKnife stereotactic body radiotherapy for adrenal tumors (primary and metastatic): Winthrop University hospital experience","volume":"5","author":"Desai","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.rpor.2015.05.009","article-title":"SBRT: a viable option for treating adrenal gland metastases","volume":"20","author":"Ippolito","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.canrad.2017.05.005_bib0190","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34\u00a0patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0195","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0003-4975(00)02509-1","article-title":"Resection of adrenal metastases from non-small cell lung cancer: a multicenter study","volume":"71","author":"Porte","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2017.05.005_bib0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0096-5588(20)30197-5","article-title":"Direct lymphatic connections from the lower lobes of the lung to the abdomen","volume":"35","author":"Meyer","year":"1958","journal-title":"J Thorac Surg"},{"key":"10.1016\/j.canrad.2017.05.005_bib0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0003-4975(97)01284-8","article-title":"Adrenalectomy for a solitary adrenal metastasis from lung cancer","volume":"65","author":"Porte","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2017.05.005_bib0210","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.2147\/OTT.S107106","article-title":"Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor","volume":"9","author":"Wang","year":"2016","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.canrad.2017.05.005_bib0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","article-title":"Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer","volume":"187","author":"Holy","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7785\/tcrt.2012.500379","article-title":"The effectiveness of a pneumatic compression belt in reducing respiratory motion of abdominal tumors in patients undergoing stereotactic body radiotherapy","volume":"13","author":"Lovelock","year":"2014","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2017.05.005_bib0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000322413","article-title":"Locating and targeting moving tumors with radiation beams","volume":"43","author":"Keall","year":"2011","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pneumo.2013.10.001","article-title":"Apport des nouvelles techniques en radioth\u00e9rapie thoracique","volume":"70","author":"Henni","year":"2014","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.canrad.2017.05.005_bib0235","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2014.55.4675","article-title":"Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice","volume":"32","author":"Timmerman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00066-011-2207-9","article-title":"Stereotactic body radiation therapy (SBRT) for adrenal metastases: a feasibility study of advanced techniques with modulated photons and protons","volume":"187","author":"Scorsetti","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic body radiotherapy for treatment of adrenal metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.05.005_bib0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.canrad.2017.05.005_bib0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2017.05.005_bib0260","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","article-title":"Stereotactic radiotherapy for adrenal gland metastases: university of Florence experience","volume":"82","author":"Casamassima","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.05.005_bib0265","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fon.10.165","article-title":"Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy","volume":"7","author":"Torok","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0275","doi-asserted-by":"crossref","first-page":"s89","DOI":"10.1016\/j.ijrobp.2011.06.181","article-title":"Stereotactic body radiotherapy vs surgery for treatment of isolated adrenal metastases: a matched pair analysis inclufding 62\u00a0patients","volume":"81","author":"Arnaud","year":"2011","journal-title":"Int J radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2017.05.005_bib0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13566-012-0037-8","article-title":"Stereotactic body radiotherapy for adrenal metastases from lung cancer","volume":"1","author":"Guiou","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0285","doi-asserted-by":"crossref","first-page":"e80654","DOI":"10.1371\/journal.pone.0080654","article-title":"Treating adrenal tumors in 26\u00a0patients with CyberKnife: a mono-institutional experience","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.canrad.2017.05.005_bib0290","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s00268-014-2454-x","article-title":"Adrenal metastectomy is safe in selected patients","volume":"38","author":"Romero Arenas","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.canrad.2017.05.005_bib0295","doi-asserted-by":"crossref","first-page":"20150111","DOI":"10.1259\/bjr.20150111","article-title":"The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly","volume":"88","author":"Scorsetti","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0300","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","article-title":"Stereotactic ablative radiotherapy for adrenal gland metastases: factors influencing outcomes, patterns of failure and dosimetric thresholds for toxicity","volume":"7","author":"Chance","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/COC.0b013e31821f876a","article-title":"Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors","volume":"35","author":"Barney","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0310","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.revmed.2016.02.007","article-title":"L\u2019insuffisance surr\u00e9nalienne chez l\u2019adulte","volume":"37","author":"Jublanc","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.canrad.2017.05.005_bib0315","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.294.19.2481","article-title":"Adrenal insufficiency","volume":"294","author":"Salvatori","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2017.05.005_bib0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2017.05.005_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"D\u00e9lin\u00e9ation des organes \u00e0 risque et contraintes dosim\u00e9triques","volume":"20","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181730152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181730152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:25:58Z","timestamp":1761135958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181730152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S127832181730152X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2017.05.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique hypofractionn\u00e9e des m\u00e9tastases surr\u00e9naliennes","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}